Bulletin
Investor Alert

Intellia Therapeutics Inc.

NAS: NTLA

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 20, 2022, 7:54 p.m.

/zigman2/quotes/207821052/composite

$

47.50

Change

-0.24 -0.50%

Volume

Volume 14,373

Quotes are delayed by 20 min

/zigman2/quotes/207821052/composite

Previous close

$ 47.71

$ 47.74

Change

+0.03 +0.06%

Day low

Day high

$43.49

$50.20

Open

52 week low

52 week high

$38.85

$202.73

Open

Glenn Goddard

Currently, Glenn Goddard is Executive VP, Chief Financial & Accounting Officer at Intellia Therapeutics, Inc.

He previously was Senior Vice President-Finance of Agios Pharmaceuticals, Inc., Chief Financial Officer of Generation Bio Co., Controller of ImmunoGen, Inc., Vice President-Finance for Archemix Corp., Principal at Ernst & Young LLP and Principal at Feeley & Driscoll PC.

He received an undergraduate degree from Bentley University.

Transactions

Date Shares Transaction Value
03/01/2022 12,720   Award at $0 per share. 0
01/01/2022 1,013   Disposition at $112.24 per share. 113,700
01/01/2022 3,062   Derivative/Non-derivative trans. at $0 per share. 0
09/07/2021 3,482   Disposition at $180.12 per share. 627,178
09/07/2021 3,482   Derivative/Non-derivative trans. at $14.58 per share. 50,767
08/31/2021 24,800   Disposition at $160.22 per share. 3,973,456
08/31/2021 1,817   Derivative/Non-derivative trans. at $14.58 per share. 26,491
08/31/2021 22,983   Derivative/Non-derivative trans. at $19.27 per share. 442,882
08/30/2021 300   Disposition at $160.84 per share. 48,252
08/30/2021 300   Disposition at $159.53 per share. 47,859
08/30/2021 300   Disposition at $158.42 per share. 47,526
08/30/2021 496   Disposition at $157.33 per share. 78,036
08/30/2021 300   Disposition at $156.1 per share. 46,830
08/30/2021 1,700   Disposition at $155.29 per share. 263,993
08/30/2021 1,100   Disposition at $154.29 per share. 169,719
08/30/2021 704   Disposition at $153.22 per share. 107,867
08/30/2021 5,200   Derivative/Non-derivative trans. at $19.27 per share. 100,204
08/05/2021 530   Disposition at $152.13 per share. 80,629
08/05/2021 9,568   Disposition at $151.41 per share. 1,448,691
08/05/2021 9,902   Disposition at $150.65 per share. 1,491,737
08/05/2021 20,000   Derivative/Non-derivative trans. at $19.27 per share. 385,400

Officers and Executives

Dr. John M. Leonard
President, Chief Executive Officer & Director
Mr. Glenn Goddard
Treasurer, Chief Financial & Accounting Officer
Dr. Laura Sepp-Lorenzino
Chief Scientific Officer & Executive VP
Dr. Eliana Clark
Chief Technology Officer & Executive VP
Dr. David Lebwohl
Chief Medical Officer & Executive Vice President
Dr. Christine Foster
SVP-Business Development & Alliance Management
Mr. Derek Hicks
Chief Business Officer & Executive Vice President
Mr. Ian Karp
Senior Vice President-Corporate Communications
Ms. Marika St Amand
Chief Human Resources Officer
Mr. James Basta
Secretary, Executive VP & General Counsel
Dr. Frank A. G. M. Verwiel
Chairman
Mr. John Francis Crowley
Independent Director
Dr. Georgia Keresty
Independent Director
Ms. Muna Bhanji
Independent Director
Dr. Jean-Francois B. Formela
Independent Director
Ms. Caroline D. Dorsa
Independent Director
Dr. Jesse L. Goodman
Independent Director
Dr. Fred Ehrenkranz Cohen
Independent Director
Link to MarketWatch's Slice.